Renaissance Technologies - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 75 filers reported holding OCULAR THERAPEUTIX INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$393
+207.0%
125,200
+403.0%
0.00%
Q2 2023$128
-65.9%
24,893
-65.0%
0.00%
Q1 2023$375
-54.6%
71,193
-75.8%
0.00%
-100.0%
Q4 2022$826
-98.6%
293,993
+1887.4%
0.00%
Q3 2022$61,000
-96.0%
14,793
-96.1%
0.00%
-100.0%
Q2 2022$1,534,000
-39.3%
381,500
-25.3%
0.00%
-33.3%
Q1 2022$2,528,000
+353.0%
510,805
+537.7%
0.00%
+200.0%
Q4 2021$558,000
-77.3%
80,100
-67.5%
0.00%
-66.7%
Q3 2021$2,462,000
-46.9%
246,200
-24.7%
0.00%
-50.0%
Q2 2021$4,639,000
+466.4%
327,122
+555.6%
0.01%
+500.0%
Q1 2021$819,000
-88.2%
49,900
-85.1%
0.00%
-87.5%
Q4 2020$6,915,000
+738.2%
334,066
+275.8%
0.01%
+700.0%
Q1 2017$825,000
-32.0%
88,900
-38.7%
0.00%
-50.0%
Q4 2016$1,214,000
+418.8%
145,100
+206.8%
0.00%
Q2 2016$234,000
+1.3%
47,300
+330.3%
0.00%
-100.0%
Q2 2015$231,00010,9920.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2016
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders